Important: This product is not authorized for administration until further notice by the FDA.
Labeler
Vaccine Procedure
Payment Allowance
Effective From
Effective To
Footnotes
My Fee
Eli Lilly
Intravenous injection, bebtelovimab, includes injection and post administration monitoring
$350.50
2022-02-11
TBD
[3][11]
(your fee)
[3] These rates will be geographically adjusted for many providers.
[11] On November 30, 2022, the FDA announced that bebtelovimab isn’t currently authorized in any U.S. region because it isn’t expected to neutralize Omicron sub-variants BQ.1 and BQ.1.1. Therefore, you may not administer bebtelovimab to treat COVID-19 under the EUA until further notice.
Quick, Current, Complete - www.findacode.com